Incidence Trends of Urinary Bladder and Kidney Cancers in Urban Shanghai, 1973-2005

Yang, Yang; Xie, Li; Zheng, Jiali; Tan, Yuting; Zhang, Wei; Xiang, Yong‐Bing

doi:10.1371/journal.pone.0082430

Cited by 10 publications

(10 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In agreement with previous studies of western countries which specified an increasing trend toward incidence of urinary bladder and kidney cancers (22), in this study incidence of urinary system cancers 23.2% was increased between 2011 and 2015. Previous publications confirmed that, there is a change to older-in-age scattering in Iran as a developing country (23).…”

Section: Discussionsupporting

confidence: 93%

Cancers of Urinary System; Prevalence, Demographic

Ghamari

2019

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

Objectives: This investigation aimed to clarify the period prevalence (PP) and incidence rate (Irs) related to cancers of the urinary system in Isfahan province, Iran. Methods: Recorded data were obtained from the Isfahan Cancer Registry. The location of cancers was distinguished from the related established topography code (C64-C68). Period prevalence (PP) and Irs was identified per 100000 persons. Results: There were 2117 patients with urinary system cancers. The mean age ± SD was 63.6 ± 14.9 years old, which in 62% ranged between 20 and 70 years. A value of 42.5 was calculated for PP that was associated with values of 66.4 for males and 17.9 for females (P < 0.001). The total PP corresponded to values of 33.2 for bladder, 8.1 for a kidney, 0.42 for renal pelvis, 0.36 for ureter and 0.38 for other unspecified related organs. Of these populations, the estimated living cases corresponded to 368 females and 1513 males. Conclusions: The PP for urinary system cancers in male population was 3.7 times higher than females. There was a 23.2% increase in the Irs over the study period. These findings highlighted the advantage of a focus on the risk of urinary system diseases, its evidence based pharmacotherapy and surgical management of such patients. In this process, providing clinical drug-management has potential importance in Iran.

show abstract

Section: Discussionsupporting

confidence: 93%

Cancers of Urinary System; Prevalence, Demographic

Ghamari

2019

Jundishapur J Chronic Dis Care

View full text Add to dashboard Cite

show abstract

“…9 Yang et al for example refers to a possible underreporting of disease. 10 Also, Villanueva et al in his study discusses the need to improve epidemiological surveillance programs, and the creation of better prevention and treatment programs.…”

Section: Resultsmentioning

confidence: 99%

“…10 Zheng et al discusses how the prevalence of cancer is higher in urban areas compared to rural ones and how this is associated with increased life expectancy. 25 In Korea the incidence was slightly lower than in Japan, furthermore Jung et al describes mortality in men of 2,3/100 000 and 0,9/100 000 in women, with a 5-year survival of 77,7 %.…”

Section: Asia and Oceaniamentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology of renal cancer in developing countries: Review of the literature

Medina-Rico

Ramos

Lobo

et al. 2017

CUAJ

View full text Add to dashboard Cite

Introduction: Renal cell carcinoma (RCC) is the ninth most common cancer in men, and the 14th most common cancer in women. It has been reported that the incidence of RCC is rising. These changes are more common in developed countries because of better screening programs and disease registry. The aim of this article is to review the epidemiology of RCC around the world. Methods: A literature review on four databases was performed: PubMed, Embase, Lilacs, and Scielo. Studies of incidence, prevalence, mortality, and survival of RCC were taken from different countries. Studies included were published in the last 10 years. Two reviewers independently selected the studies. Results: A total of 5275 references were reviewed by title and abstract. In the end, 42 references were selected for full-text review. The global incidence and prevalence of cancer vary. The highest incidence was described in North America and Northern Europe. In Canada, by 2007 the incidence was 17.9/100 000 and 10.3/100 000 in males and females, respectively. Developing countries like Colombia have fewer incidence rates, finding less information in poor-income areas. Conclusions:We have seen a rise in the incidence and mortality of RCC globally. There is an association between RCC and smoking, obesity, hypertension, and socioeconomic status. Seeing the epidemiological data from some regions in developing countries and the lack of specialists in those places, it can be deduced the existence of an underreporting of

show abstract

“…33 Dos estudios concluyeron un aumento de la incidencia del cáncer de vejiga con los años pasando de 6,39/100.000 en 1973 a 7,66/100.000 en 2005; adicionalmente se encontró que desde 1973 hasta 2009 hubo un aumento de la mortalidad en áreas rurales y una disminución en áreas urbanas, posiblemente por la exposición ocupacional que puede presentar la población rural. 34,35 En Japón, Masayoshi Z y col. encontraron una sobrevida a 5 años del 56% para hombres y 49% para mujeres. 36 En Nepal, Poudel K y col. describieron una incidencia de 0,98/100.000, siendo el CV el quinto cáncer más común en el país.…”

Section: Asia Y Oceaníaunclassified

Epidemiología del cáncer de vejiga con énfasis en Colombia - revisión de la literatura

et al. 2018

View full text Add to dashboard Cite

Introducción El cáncer de vejiga es el noveno cáncer más frecuente para ambos sexos con una incidencia en ascenso. Habiendo una aparente relación entre el desarrollo de los países y la epidemiología del cáncer; el objetivo de este artículo es observar la epidemiología del cáncer de vejiga en nuestro medio respecto a otros países y describir los posibles factores asociados. Métodos Se realizó una revisión de la literatura en cuatro bases de datos: Medline, Embase, Cochrane database y Lilacs. Se incluyeron estudios de incidencia, prevalencia, mortalidad, sobrevida y carga de enfermedad, publicados en los últimos 5 años. Resultados Se encontraron 7806 referencias que fueron discriminadas por título y resumen, incluyendo al final 44 referencias en texto completo. Se observaron tasas de incidencia y mortalidad diferentes, siendo las más altas las encontradas en Europa principalmente en la República Checa seguido de Norte América. En Colombia, la incidencia general es de 6,8/100.000 en hombres y 2,1/100.000 en mujeres entre 2003 y 2007, encontrando cifras bajas en departamentos como la Guajira. Conclusiones Se ha observado un ascenso en la incidencia y mortalidad del cáncer de vejiga a nivel global. Parece haber una asociación con el tabaquismo y la dieta, así como con el Índice de Desarrollo Humano. Existe una escasa información en Latino América. En Colombia, observando los datos de algunos departamentos y la distribución de especialistas por regiones, se puede suponer un sub-registro haciendo necesario mejorar los sistemas de vigilancia, así como las políticas de salud para el diagnóstico e intervención temprana del cáncer.

show abstract

Incidence Trends of Urinary Bladder and Kidney Cancers in Urban Shanghai, 1973-2005

Cited by 10 publications

References 31 publications

Cancers of Urinary System; Prevalence, Demographic

Cancers of Urinary System; Prevalence, Demographic

Epidemiology of renal cancer in developing countries: Review of the literature

Epidemiología del cáncer de vejiga con énfasis en Colombia - revisión de la literatura

Contact Info

Product

Resources

About